The incidence of breast cancer is high, but the mortality rate is low, the rate of early breast cancer treatment is over 90 per cent and treatment of early breast cancer is now targeted at cure. Emphasis is therefore placed on breast cancer screening, early diagnosis and early treatment.
The development of breast cancer cancer cells in humans is a considerable process. It is divided into four main stages, namely, concealment, early leaching, immersion (progressive breast cancer) and late breast cancer. As the roots grow, as the annual wheels grow, they gradually spread underground.
Phase I: Hiding
The hidden phase is also referred to as the pre-cancer phase, which lasts from 6 to 20 years. In this development, it is generally accepted that in situ cancer of the catheter (also known as internal cancer of the catheter) is a pre-disposal to leaching cancer. Breast cells in the human body experience cancer and in situ cancer, which is also the development of early immersion.
Phase II: Early leaching of cancer
The early immersion of cancer is about the time when the cancer cell begins to immerse the mesotheliated meme through the mesotheliation of the skin on the breast catheter. Simplely speaking, it is like a tree that breaks through the surface and starts preparing to take root, which is different from in situ cancer and from general immersion cancer, with visible cancer cell nests scattered in the interstate of the breast, which can be divided into early immersional leaf cancer and catheter cancer.
Phase III: Vaccination stage (promulgated breast cancer)
The cancer cells at this stage began to be immersed in a wide range of breast meterogenesis, and the cancer tissues and intermechanics were mixed with each other, resulting in variable pathological images. That is to say, the roots of the trees at this time are no longer content with their one acre or three parts, and they begin to spread to the surrounding land and produce many branches to make their roots stronger and stronger. In the case of breast cancer, there is a marked increase in the probability of transfer through lymphoma or blood lines. The tumour developed faster during this period, with tumours growing in diameter from less than 1 cm to more than 5 cm, also known as progressive breast cancer.
Phase IV: Late breast cancer
The tumour has grown to a very high level during this period, and most patients experience different levels of cancer transfer. The roots at this time were also not satisfied with single-sapling seedlings and began to plant seeds into other lands to expand their territory. If breast cancer during this period is not treated in a timely manner, the cancer cell is widely transmitted in the human body, mainly in the lung, liver, bone, etc., and in different places or places, seriously endangering the life of the patient.
Breast cancer has been found to be safe, early diagnosis and early treatment have increased as much as possible, and, as medicine continues to develop, the incidence of breast cancer worldwide has increased by 3 per cent per year over the past 10 years, but the rate of survival of breast cancer has increased by 20 per cent and the rate of survival of breast cancer has been high for five years (83.2 per cent).
How are early treatments for breast cancer patients?
Initial breast cancer treatment methods include surgery, treatment, chemotherapy, endocrine treatment, targeting treatment, etc., as follows:
1. Surgery: The first routine procedure for breast cancer includes breast retention and whole-milk removal. In the course of the operation, it may be necessary to clear the lymph nodes in the armpits, to determine whether they have been transferred and to help determine the programme of follow-up support treatment.
2 Release: Breast cancer often requires after surgery to kill cancer cells left behind and reduce the risk of relapse.
3 Chemotherapy: chemotherapy is mainly provided through intravenous infusion of anti-cancer drugs to eliminate the micro-diversion of cancer cells in the whole body, and to prevent post-octology relapse and transfer.
4. Endocrine treatment: estrogen receptor-positive breast cancer, use of endocrine treatment to disrupt estrogen effects to prevent the growth and transfer of tumours.
5. Target treatment: For Sher2-positive breast cancers, the target-oriented drug is often used to inhibit cancer cell growth.
Attention is drawn to the fact that specific treatment programmes should be determined on the basis of the patient ‘ s specific circumstances and conditions and therefore require timely access to hospitals for treatment.
